INTRODUCTION
Despite the decreasing incidence and mortality of gastric cancer, it remains one of the most common types of cancer and is an important cause of cancer-related deaths in East Asian countries, such as Korea and Japan [1] . A high incidence of gastric cancer in this region has often been attributed to a high rate of Helicobacter pylori infection. In 1994, the World Health Organization (WHO) classified H. pylori as a definite carcinogen based on thesurgery.or.kr large-scale epidemiological data [2] . Since the publication the WHO classification, several prospective studies have determined a strong correlation between H. pylori and gastric cancer development and have indicated that the eradication of H. pylori could prevent the progression of gastric cancer [3] [4] [5] .
The 5-year survival rate has increased to 60 due to a higher rate of early stage diagnoses through mass screening programs in areas of high gastric cancer incidence coinciding with H. pylori epidemic areas. However, greater than 40 of gastric cancer patients are still diagnosed at an advanced stage with a comparatively lower overall survival rate [6] . Patients who are predicted to have a poor prognosis may require aggressive surgical procedures or additional perioperative therapy. Therefore, it is important to understand the factors that are predictive of overall or disease-free survival prior to treatment onset.
Although the prognosis for gastric cancer patients is based on the tumor-node-metastasis (TNM) stage, there is a range of prognoses within similar stages that cannot be fully explained. Although a strong correlation between H. pylori and gastric cancer development has been established, the effect of H. pylori status on the prognosis of gastric cancer patients has not been reported in Eastern societies, which are well-known H. pylori endemic areas. Two prospective studies have reported that a negative H. pylori status is associated with an improved prognosis in Western countries [7, 8] ; however, these results are not globally applicable due to regional differences in H. pylori virulence and gastric cancer incidence [9] . Therefore, the determination of the relationship between gastric cancer patient prognosis and H. pylori status is relevant in areas of high H. pylori prevalence.
Here, we made a plan to collect prospectively the data of gastric cancer patients in Korea, where H. pylori is highly prevalent, to assess the correlation between the H. pylori status of patients who underwent curative resection for the treatment of gastric adenocarcinoma and their prognosis. Values are presented as number (%). AJCC, American Joint of Cancer Committee. A chi-squared test was used to analyse correlations between the clinicopathologic features and H. pylori status.
METHODS
Overall and disease-free survival and H. pylori status were analysed using the Kaplan-Meier test. The factors that predicted cancer recurrence were analysed using the Cox proportional hazard regression model. Statistical analyses were performed using SPSS ver. 13.0 (SPSS Inc., Chicago, IL, USA), and P-values ＜ 0.05 were considered statistically significant.
RESULTS
A total of 149 patients (85.5%) were serologically pos-thesurgery.or.kr The mean survival time of all patients was 36.4 months, and the mean disease-free survival time was 34.8 months.
During the follow-up period, 30 patients had recurrence, and 23 patients died. The overall and disease-free survival of the patients were significantly decreased with increasing tumour staging (P ＜ 0.001) (Fig. 1) . However, H. pylori infection status did not have a significant effect on the overall or disease-free survival (Fig. 2) .
A subgroup analysis was performed by dividing the patients into two groups according to their AJCC stage (stages I or II and III or IV). In patients with stage I or II cancer, a younger age (P = 0.003) and reduced tumour invasion (P = 0.020) were significantly associated with an improved overall survival; a younger age (P = 0.006) was also associated with a higher disease-free survival rate.
However, H. pylori infection status did not significantly correlate with the overall (P = 0.396) or disease-free survival (P = 0.793) ( Table 2 ).
In stage III or IV cases, lymph node involvement was associated with the overall and disease-free survival. The disease-free survival of patients negative for H. pylori in- fections was significantly shorter than that of patients with a positive H. pylori status (P = 0.019) ( Table 3 ). In addition, the overall survival did not differ significantly according to the H. pylori status (P = 0.302) (Fig. 3) . In the multivariable analysis, a negative H. pylori status (relative risk, 2.724; 95 confidence interval, 1.192 to 6.228) was predictive of an early recurrence accompanied by lymph node involvement (Table 4) .
DISCUSSION
Patients diagnosed with advanced stage gastric cancer have a poor prognosis despite resection of the primary tumour and perigastric lymph nodes. The most reliable factor for predicting the prognosis of gastric cancer patients appears to be TNM stage, which is based on the level of invasion and metastasis to local lymph nodes [12, 13] . In our study, the overall and disease-free survival were sig- for some time, and preoperative assessment is possible.
The results of our study indicated that H. pylori status could be a predictive factor for early recurrence in patients at an advanced stage of gastric cancer. [7, 8] . Compared to previous research, the critical difference in our study was that the patients were enrolled in Korea, which is a country with a high rate of H. pylori infection. To the best of our knowledge, this study is the first to suggest that H. pylori infection is a superior prognostic factor in a population with a high prevalence of H. pylori. Several studies have demonstrated that gastric cancer patients in Eastern societies exhibit improved survival rates relative to patients in Western populations [18, 19] . These studies proposed that survival differences may be dependent on differences in Western countries have demonstrated that perigastric lymph node dissection followed by gastrectomy was sufficient in the treatment of all localised gastric cancers based on cancer survival and operative morbidity [20, 21] .
However, the surgical strategy used in our institution has followed the Japanese perspective, which recommends extended lymphadenectomy (over D1 + β lymph node dissection) for gastric cancer with invasion of tumours as small as T1 [22] . The aggressive resection of localised gas- 
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